Which medications can cause an elevation of serum lipase and amylase?

Medications That Can Cause Lipase and Amylase Elevation

The most clinically significant drug-induced elevations of lipase and amylase occur with thiopurines (azathioprine/6-mercaptopurine), pentavalent antimonials, immune checkpoint inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, nilotinib, and pentamidine.

High-Risk Medications by Drug Class

Immunosuppressants & Inflammatory Bowel Disease Medications

• Azathioprine and 6-mercaptopurine cause dose-independent pancreatitis in approximately 4% of IBD patients, typically within the first 3-4 weeks of treatment 1. The risk is higher in Crohn's disease and in patients carrying the HLA-DQA102:01-HLA-DRB107:01 haplotype 1.
• 5-ASA compounds have a much lower risk than thiopurines but can still cause enzyme elevations 1.

Antiparasitic Agents

• Pentavalent antimonials (sodium stibogluconate, meglumine antimoniate) commonly cause reversible elevations in aminotransferase, lipase, and amylase values during treatment 2, 3. Therapy should be interrupted if moderate-to-severe clinical pancreatitis develops 2.
• Pentamidine isethionate causes pancreatitis and can lead to insulin-dependent diabetes mellitus that may be diagnosed months post-treatment 3.

Oncology Medications

Immune Checkpoint Inhibitors:

• Anti-PD-1/PD-L1 and anti-CTLA-4 agents cause asymptomatic pancreatic enzyme elevations 4, 5.
• Critical distinction: Routine monitoring of amylase or lipase in asymptomatic patients is NOT recommended 4, 5. Only investigate if symptoms develop.
• For moderate symptomatic pancreatitis, hold immunotherapy and initiate high-dose steroids with a 6-week taper 5. For severe cases, permanently discontinue 5.

Tyrosine Kinase Inhibitors:

• Nilotinib causes grade 3 elevations in lipase, amylase, bilirubin, and hepatic transaminases 6. When grade 3 elevations occur, hold the drug until levels return to grade 1, then resume at reduced dose (400 mg once daily) 6.

Antidiabetic Medications

• GLP-1 receptor agonists (e.g., liraglutide) cause dose-independent, reversible increases: mean 7% elevation in amylase and 31% elevation in lipase over 56 weeks 7. More participants experience lipase elevations ≥ULN (43.5%) than amylase elevations (9.4%) 7.
• DPP-4 inhibitors show similar patterns, with 36% of patients experiencing increased amylase or lipase, predominantly affecting lipase more than amylase 8.
• Important: Enzyme elevations (either 1×ULN or ≥3×ULN) have very low positive predictive value (<1%) for actual pancreatitis 7. Do not monitor enzymes routinely except when pancreatitis is suspected 7.

Other Medications

• Corticosteroids are associated with increased lipase levels 9.
• Enalapril correlates with high serum lipase levels 9.
• Intravenous cotrimoxazole (especially for Pneumocystis pneumonia treatment) causes elevations, particularly in HIV patients 10.
• Antiretroviral therapy can cause transient lipase elevations within 3 months of initiation 10.

Clinical Management Algorithm

When Enzymes Are Elevated:

1. Assess for symptoms: Abdominal pain, nausea, vomiting

   • If symptomatic → workup for acute pancreatitis (imaging, clinical criteria)
   • If asymptomatic → proceed to step 2

2. Review medication list for the drugs listed above

   • For thiopurines: Discontinue immediately if any elevation occurs 1
   • For GLP-1/DPP-4 inhibitors: Discontinue if any elevation; enzymes return to baseline after stopping 7, 8
   • For checkpoint inhibitors: Do NOT discontinue for asymptomatic elevations 4, 5
   • For nilotinib: Hold until grade ≤1, then resume at reduced dose 6

3. Rule out other causes:

   • Gallstones (most common non-drug cause in general population)
   • Renal insufficiency (check creatinine) 9
   • Chronic hepatitis B or C 10
   • Alcohol use
   • Bowel obstruction, cholecystitis, appendicitis 11

4. Monitor appropriately:

   • For thiopurines: Normalization typically occurs within 2 months after stopping 12
   • For GLP-1 agonists: Enzymes return to baseline after discontinuation 7
   • Persistent elevation beyond expected timeframe warrants imaging to exclude chronic pancreatic disease 13

Critical Pitfalls to Avoid

• Do NOT routinely monitor pancreatic enzymes in asymptomatic patients on checkpoint inhibitors or GLP-1 agonists 4, 5, 7.
• Do NOT assume elevated enzymes equal pancreatitis: 7% of IBD patients have asymptomatic elevated lipase without pancreatitis 1.
• Do NOT continue thiopurines after any enzyme elevation—the risk of progression to clinical pancreatitis is significant 1.
• Do NOT forget to check renal function: Renal insufficiency is a common cause of isolated enzyme elevations 9.
• Lipase is more sensitive and remains elevated longer than amylase (8-14 days vs 3-7 days) 11, making it the preferred test for pancreatitis diagnosis.